what are glp-1 medications Medications: Everything You Need to Know Why Is Everyone Excited About
Description
Chang YF, Zhang D, Hu WM, et al
Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, et al
48% of patients achieved more than 25% weight loss compared to 0% on lifestyle changes alone
A Sanofi spokesperson told BioSpace in an emailed statement that the company made the strategic decision of focusing on offering the combination therapy Soliqua consisting of GLP-1 and basal insulin to help people manage their diabetes. The spokesperson added that Soliqua has since become one of the cornerstone therapies in its diabetes portfolio and represents an important growth asset for the company
The study came out of a curiosity we had, since we certainly are seeing a lot more patients in the clinic on these therapies who are effectively losing weight, he says
